{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01753440",
      "OrgStudyIdInfo": {
        "OrgStudyId": "AHEPA_CTL_01"
      },
      "Organization": {
        "OrgFullName": "AHEPA University Hospital",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Allogeneic Stem Cells Implantation Combined With Coronary Bypass Grafting in Patients With Ischemic Cardiomyopathy",
      "OfficialTitle": "Study on the Safety and Efficacy of Allogeneic Mesenchymal Stem Cell Implantation Combined With Bypass Grafting in Patients With Coronary Artery Disease and Ischemic Cardiomyopathy."
    },
    "StatusModule": {
      "StatusVerifiedDate": "May 2019",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "November 2012",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "September 2014",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 2014",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "December 18, 2012",
      "StudyFirstSubmitQCDate": "December 19, 2012",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "December 20, 2012",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "May 3, 2019",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "May 7, 2019",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Kyriakos Anastasiadis",
        "ResponsiblePartyInvestigatorTitle": "Professor Kyriakos Anastasiadis",
        "ResponsiblePartyInvestigatorAffiliation": "AHEPA University Hospital"
      },
      "LeadSponsor": {
        "LeadSponsorName": "AHEPA University Hospital",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The aim of the present study is to investigate safety and efficacy of intramyocardial implantation of a novel mesenchymal precursor cell type (iMP) in patients with ischemic cardiomyopathy at the time of coronary artery bypass grafting.",
      "DetailedDescription": "This study aims to investigates in situ cardiac regeneration utilizing precision delivery of a novel mesenchymal precursor cell type (iMP) during coronary artery bypass surgery (CABG) in patients with ischemic cardiomyopathy (LVEF < 40 %). Preoperative scintigraphy imaging (SPECT) will be used to identify hibernating myocardium not suitable for conventional myocardial revascularization for iMP implantation. iMP cells will be implanted intramyocardially in predefined viable peri-infarct areas that show poor perfusion, which could not be grafted due to poor target vessel quality. Postoperatively, SPECT will be used to identify changes in scar area."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Coronary Artery Disease",
          "Ischemic Cardiomyopathy"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "coronary artery disease",
          "heart failure",
          "stem cells implantation"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "11",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Stem cells implantation",
            "ArmGroupType": "Other",
            "ArmGroupDescription": "Patients with severe coronary artery disease and chronic ischemic cardiomyopathy with a LVEF ≤40% who are scheduled for elective CABG according to accepted guidelines. Additional criteria include the following: age <75 years, history of myocardial infarction (not less than 14 days before the procedure), LVEF ≤40 % assessed with echocardiography, and a distinct area of dyskinetic or akinetic left ventricular myocardium corresponding with the infarct localization.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Procedure: Intramyocardial implantation of of a novel mesenchymal precursor cell type (iMP)."
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Procedure",
            "InterventionName": "Intramyocardial implantation of of a novel mesenchymal precursor cell type (iMP).",
            "InterventionDescription": "Intramyocardial implantation of a novel mesenchymal precursor cell type (iMP).",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Stem cells implantation"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "iMP-related adverse events",
            "PrimaryOutcomeDescription": "Major adverse cardiac and cerebrovascular events including death, postoperative myocardial infarction, need for revascularization, stroke, hospitalization for worsening heart failure, myocardial rupture, infectious myocarditis, or sustained ventricular arrhythmias.",
            "PrimaryOutcomeTimeFrame": "12 months"
          },
          {
            "PrimaryOutcomeMeasure": "Hypersensitivity",
            "PrimaryOutcomeDescription": "Hypersensitivity reaction (fever, urticaria, hemolytic anemia, hypotension, immune thrombocytopenia)",
            "PrimaryOutcomeTimeFrame": "12 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Scar reduction",
            "SecondaryOutcomeDescription": "Myocardial scar size reduction assessed with SPECT",
            "SecondaryOutcomeTimeFrame": "4 months"
          },
          {
            "SecondaryOutcomeMeasure": "Scar reduction",
            "SecondaryOutcomeDescription": "Myocardial scar size reduction assess with SPECT",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "LVEF",
            "SecondaryOutcomeDescription": "Left ventricular ejection fraction",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Change in quality of life",
            "SecondaryOutcomeDescription": "Quality of life evaluated with MLHFQ",
            "SecondaryOutcomeTimeFrame": "12 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nAge from 18 to 75 years\nSevere coronary artery disease amenable to surgical revascularization according to current guidelines\nHistory of acute myocardial infarction at least 14 days previously\nLeft ventricular ejection fraction (LVEF) ≤ 40% as assessed with echocardiography\nDistinct area of dyskinetic or akinetic left ventricular myocardium corresponding with the infarct localization\nPatient's informed consent obtained\n\nExclusion Criteria:\n\nEmergency operation\nDebilitating chronic disease (eg. malignancy or terminal renal failure)\nConcomitant valve surgery\nPrevious cardiac surgery\nMalignant ventricular arrhythmias\nHaematologic disease\nWoman in reproductive age\nSevere psychiatric illness",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "75 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Kyriakos Anastasiadis, MD, PhD FETCS",
            "OverallOfficialAffiliation": "AHEPA University Hospital",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "AHEPA University Hospital",
            "LocationCity": "Thessaloniki",
            "LocationZip": "546 36",
            "LocationCountry": "Greece"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "23117550",
            "ReferenceType": "background",
            "ReferenceCitation": "Hare JM, Fishman JE, Gerstenblith G, DiFede Velazquez DL, Zambrano JP, Suncion VY, Tracy M, Ghersin E, Johnston PV, Brinker JA, Breton E, Davis-Sproul J, Schulman IH, Byrnes J, Mendizabal AM, Lowery MH, Rouy D, Altman P, Wong Po Foo C, Ruiz P, Amador A, Da Silva J, McNiece IK, Heldman AW, George R, Lardo A. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA. 2012 Dec 12;308(22):2369-79. Erratum in: JAMA. 2013 Aug 21;310(7):750. George, Richard [added]; Lardo, Albert [added]."
          },
          {
            "ReferencePMID": "21852003",
            "ReferenceType": "background",
            "ReferenceCitation": "Anastasiadis K, Antonitsis P, Doumas A, Koliakos G, Argiriadou H, Vaitsopoulou C, Tossios P, Papakonstantinou C, Westaby S. Stem cells transplantation combined with long-term mechanical circulatory support enhances myocardial viability in end-stage ischemic cardiomyopathy. Int J Cardiol. 2012 Mar 22;155(3):e51-3. doi: 10.1016/j.ijcard.2011.07.062. Epub 2011 Aug 17."
          },
          {
            "ReferencePMID": "20600097",
            "ReferenceType": "background",
            "ReferenceCitation": "Menasche P. Cardiac cell therapy: lessons from clinical trials. J Mol Cell Cardiol. 2011 Feb;50(2):258-65. doi: 10.1016/j.yjmcc.2010.06.010. Epub 2010 Jun 30. Review."
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000003324",
            "ConditionMeshTerm": "Coronary Artery Disease"
          },
          {
            "ConditionMeshId": "D000017202",
            "ConditionMeshTerm": "Myocardial Ischemia"
          },
          {
            "ConditionMeshId": "D000003327",
            "ConditionMeshTerm": "Coronary Disease"
          },
          {
            "ConditionMeshId": "D000009202",
            "ConditionMeshTerm": "Cardiomyopathies"
          },
          {
            "ConditionMeshId": "D000007511",
            "ConditionMeshTerm": "Ischemia"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000006331",
            "ConditionAncestorTerm": "Heart Diseases"
          },
          {
            "ConditionAncestorId": "D000002318",
            "ConditionAncestorTerm": "Cardiovascular Diseases"
          },
          {
            "ConditionAncestorId": "D000001161",
            "ConditionAncestorTerm": "Arteriosclerosis"
          },
          {
            "ConditionAncestorId": "D000001157",
            "ConditionAncestorTerm": "Arterial Occlusive Diseases"
          },
          {
            "ConditionAncestorId": "D000014652",
            "ConditionAncestorTerm": "Vascular Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M9695",
            "ConditionBrowseLeafName": "Ischemia",
            "ConditionBrowseLeafAsFound": "Ischemic",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M5698",
            "ConditionBrowseLeafName": "Coronary Artery Disease",
            "ConditionBrowseLeafAsFound": "Coronary Artery Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M18658",
            "ConditionBrowseLeafName": "Myocardial Ischemia",
            "ConditionBrowseLeafAsFound": "Coronary Artery Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M5701",
            "ConditionBrowseLeafName": "Coronary Disease",
            "ConditionBrowseLeafAsFound": "Coronary Artery Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M8573",
            "ConditionBrowseLeafName": "Heart Failure",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11306",
            "ConditionBrowseLeafName": "Cardiomyopathies",
            "ConditionBrowseLeafAsFound": "Cardiomyopathy",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M8571",
            "ConditionBrowseLeafName": "Heart Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M3621",
            "ConditionBrowseLeafName": "Arteriosclerosis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M3617",
            "ConditionBrowseLeafName": "Arterial Occlusive Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16552",
            "ConditionBrowseLeafName": "Vascular Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC14",
            "ConditionBrowseBranchName": "Heart and Blood Diseases"
          }
        ]
      }
    }
  }
}